請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/1159
標題: | 利用細胞週期及微核糖核酸為基礎的邏輯匣專一性殺死上皮癌細胞 A cell-cycle and microRNA-based AND logic gate to specifically kill epithelial cancer cells |
作者: | Ming Wang 王敏 |
指導教授: | 黃筱鈞 |
關鍵字: | 癌症,抗有絲分裂,基因治療,合成生物學,核糖酸干擾,細胞週期素,微型核糖核酸,四環素控制的表現系統,絕緣子, cancer,anti-mitotic,gene therapy,synthetic biology,RNA interference,cyclin B1,microRNA,insulator, |
出版年 : | 2018 |
學位: | 碩士 |
摘要: | Anti-mitotic chemotherapy is a cancer therapy that kills cells with high division rate. Since abnormal proliferation is one of the most prominent characteristics of can-cer cells, antimitotic drugs are expected to have high selectivity and sensitivity. How-ever, non-specific targeting of hematopoietic stem cells (HSCs) that also divide rapidly is one of the most severe side effects. To overcome this problem, we constructed a synthetic AND genetic logic, utilizing two sensors, cyclin B1 promoter and miR-142-5p binding sites, in mammalian cells. miR-142-5p was chosen as it is present exclusively in hematopoietic lineages. When cells enter G2 phase of cell cycle, cyclin B1 promoter will be active to express Tet-On 3G transactivator protein. In the presence of doxycycline, the transactivator will then activate a toxic gene, here hBax-β or trun-cated caspase-3/7, tagged with miR-142-5p binding sites. In this setting, HSCs, pro-grammed with miR-142 production, toxic gene will be repressed thus cells are pro-tected, whereas in non-hematopoietic cancer cells, where miR-142 level is significant-ly lower, apoptosis will be triggered. We have successfully cloned and characterized all individual parts in the circuit and have observed the circuit’s capability to render death in HeLa cell. Moreover, we are currently optimizing the circuit by co-expressing an-other apoptotic gene and built the stable cell lines for increasing the transfection effi-cacy. However, when we construct a vector containing the two different types of pro-moter, i.e. constitutive and doxycycline-inducible, there appears to be interference between promoters. In resolving this, we tested an insulator core element and found that two tandem copies of this sequence can effectively suppress the interference. We envision our circuit will serve as a useful alterative tool for targeted cancer therapy in the near future. |
URI: | http://tdr.lib.ntu.edu.tw/handle/123456789/1159 |
DOI: | 10.6342/NTU201804309 |
全文授權: | 同意授權(全球公開) |
顯示於系所單位: | 分子與細胞生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf | 2.48 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。